MAP1LC3A and cancer: In addition, high mRNA levels of MAP1LC3A were shown to potentially activate the DNA damage response (12%) pathway, while potentially inhibit the activity of apoptosis (22%), the cell cycle (12%) and RTK (12%) pathways in pan-cancer (Figure 3a).